ARCHIVES

NCI-Approved Clinical Trials

This article is from The Cancer Letter archive.

Vol. 28 No. 12 | December 30, 2005

Download PDF Visit The Full Archive

Related Articles

Oncology Societies, Cancer Center, List Reform Principles

August 12, 1994

Phase III Trial: Panobinostat Increases PFS by Four Months

September 26, 2014

NCI Commits $8 Million More to R01s, Increases Payline to 12th Percentile. Surgeon General’s Report Says There’s No Safe Level of Secondhand Smoke.

June 30, 2006

In Brief: Susumu Tonegawa To Receive Bristol-Myers Award; Mark Green Named Director Of UCSD Cancer Center

March 7, 1986

Senators Urge study section On Clinical Cancer Research

February 4, 1994

New Data Support Claims That Costs Are Higher For Protocol Patients

August 31, 1984